safinamide has been researched along with betrixaban in 2 studies
| Studies (safinamide) | Trials (safinamide) | Recent Studies (post-2010) (safinamide) | Studies (betrixaban) | Trials (betrixaban) | Recent Studies (post-2010) (betrixaban) |
|---|---|---|---|---|---|
| 199 | 29 | 159 | 95 | 19 | 82 |
| Protein | Taxonomy | safinamide (IC50) | betrixaban (IC50) |
|---|---|---|---|
| Prothrombin | Homo sapiens (human) | 0.018 | |
| Coagulation factor X | Homo sapiens (human) | 0.0035 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 8.9 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Finn, LA; Hussar, DA | 1 |
2 other study(ies) available for safinamide and betrixaban
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
2018 New Drug Update.
Topics: Aged; Alanine; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Anticoagulants; Antiparkinson Agents; Benzamides; Benzylamines; Constipation; Drug Approval; Humans; Natriuretic Peptides; Psoriasis; Pyridines; Tardive Dyskinesia; Tetrabenazine; Valine | 2018 |